.avif)
Learn how aesthetic equipment suppliers can offer financing for lasers, IPL, RF and body-contouring systems across the U.S. and Canada.
An aesthetic clinic may want a new laser, IPL platform, radiofrequency system or body-contouring device while still needing cash for staffing, rent, marketing, supplies and the time required to build treatment volume.
That creates a financing opportunity for aesthetic equipment suppliers.
Instead of asking every clinic to arrange financing independently, the supplier can make commercial financing part of the equipment sale while an independent financing provider handles the credit decision.
Quick Answer: Aesthetic equipment suppliers can offer qualified clinics third-party financing for lasers, IPL, RF, body-contouring and other eligible systems without lending their own capital. Strong programs separate the device from software, service plans and consumables, verify regulatory status, evaluate clinic cash flow and device resale value, and define supplier-payment conditions before delivery.
A customer financing program connects the supplier's sales process with one or more independent commercial financing providers.
The supplier sells the aesthetic equipment.
The clinic, medical spa, dermatology practice or other eligible commercial buyer applies for financing.
The financing provider evaluates the buyer, device and transaction. If approved, it establishes the financing amount, term, pricing, security and closing requirements.
Once those conditions are completed, the financing provider can pay the supplier according to the transaction documents. The customer then makes payments under its financing agreement.
The supplier therefore does not necessarily need to become the lender, use its own working capital or collect payments for years after selling the device.
Canadian suppliers can use Mehmi's Medical Equipment Dealer Financing Canada as the broader medical-dealer framework. Suppliers wanting a more specialized borrower-side resource can also direct Canadian customers to Aesthetic Laser Financing Canada.
Aesthetic equipment can range from relatively straightforward treatment systems to expensive multi-application platforms containing several handpieces, software licences and service requirements.
Potential equipment can include laser hair-removal systems, CO₂ and other resurfacing lasers, picosecond and Q-switched platforms, IPL systems, radiofrequency systems, RF microneedling equipment, body-contouring devices, skin-treatment systems, cooling equipment, smoke evacuation systems and other commercially eligible treatment technology.
Eligibility depends on the specific device, jurisdiction, buyer and financing provider.
The supplier should clearly identify the equipment rather than presenting one vague "aesthetic package" price.
For example, if a CAD $180,000 transaction contains a CAD $135,000 base platform, CAD $20,000 of handpieces, CAD $10,000 of installation and training and CAD $15,000 of software or service costs, those components should be visible.
That allows underwriting to distinguish durable equipment with resale value from costs that are consumed or difficult to recover.
Mehmi's Medical & Dental Equipment Dealer Financing discusses why itemizing the complete medical-equipment package becomes especially important for higher-ticket laser and technology systems.
Aesthetic devices can depreciate differently from conventional machinery.
A ten-year-old forklift may still perform essentially the same material-handling task it performed when new.
A ten-year-old aesthetic system may still function mechanically but face greater technological obsolescence because treatment protocols, software, handpieces, manufacturer support and customer expectations have changed.
That affects collateral.
An underwriter can care about the device manufacturer, model, age, serial number, treatment platform, handpieces, service history, software transferability, remaining warranty and availability of OEM service.
A financing provider may also ask whether the device can legally be sold and operated for the proposed use.
Financing approval and device regulatory status are separate questions.
A lender being willing to finance an aesthetic device does not establish that the device is authorized for sale, correctly labelled or permitted for the buyer's intended use.
Repayment capacity still comes first.
Depending on the transaction, an underwriter may review the buyer's operating history, business and owner credit, bank activity, existing debt, profitability, liquidity and the amount the customer is contributing to the purchase.
Larger transactions can require year-end financial statements, interim results, debt schedules or additional financial information.
There is no universal credit score, revenue minimum, down-payment requirement or time-in-business standard across all aesthetic-equipment financing providers.
The reason for acquiring the device also matters.
An established clinic replacing an older laser that already produces treatment revenue presents a different case from a new medical spa acquiring several expensive platforms before opening.
Likewise, a clinic adding a treatment system after repeatedly referring customers elsewhere has a different business case from a clinic relying entirely on optimistic forecasts for an untested service line.
Underwriters may consider projected revenue, but the equipment should not require a best-case marketing outcome just to make the monthly payment affordable.
Startup customers can potentially receive financing, but the lack of historical business cash flow creates more uncertainty.
Underwriting may place greater weight on the owners' credit, relevant industry experience, available liquidity, clinic location, business readiness and the size of the initial equipment package.
A financing provider may also want to understand which entity owns the practice and which entity will sign the financing agreement.
Medical and aesthetic businesses can sometimes involve professional corporations, operating companies and management entities. The file should clearly identify where revenue is generated and which entity will own or use the device.
Suppliers should not tell a new clinic that a professional credential or strong personal credit automatically guarantees financing.
The entire transaction still needs to work.
Sometimes the financially stronger structure is to purchase one core system first and add additional technology after the practice establishes cash flow.
Not every component of an aesthetic system has the same economic life.
A reusable laser handpiece can have durable equipment value.
Single-use treatment tips, cartridges, gels and other consumables are operating expenses.
An embedded computer or transferable software licence may support the equipment's value. An ongoing SaaS subscription does not create the same collateral.
Service agreements are different again.
A three-year OEM service plan may reduce the customer's operating risk, but it does not have the same recoverable value as the device itself.
Suppliers should therefore separate the base device, durable handpieces, accessories, installation, training, software, warranties, service plans and initial consumables on the quote.
The financing provider can then determine what it is prepared to include.
This is consistent with Mehmi's broader Vendor Financing Program for OEMs and Distributors, where clean invoices and identifiable hard costs are central to a financeable vendor package.
Used aesthetic equipment can potentially be financed, but the file normally requires more diligence.
The supplier should be prepared to document the device's age, serial number, condition, maintenance history, previous ownership and included handpieces.
Pulse counts, shot counts or other usage information can matter on equipment where those measures are relevant, but no single usage number should be presented as a universal lender cutoff.
Serviceability often matters more.
An older system with ongoing OEM support, documented maintenance and readily available replacement components can present a stronger collateral case than a newer device from a manufacturer with limited support.
Software transfer is another consideration.
A buyer should know whether software licences, treatment protocols or cloud services transfer with a used unit or require a new agreement.
The financing term should reflect remaining economic life. Stretching an older device over a long repayment period merely to generate a lower payment can leave the clinic owing money after the technology has become difficult to service or commercially outdated.
Aesthetic equipment suppliers in the United States should be precise when discussing FDA status.
FDA medical devices are subject to different regulatory controls depending on device classification and whether premarket review is required. When a device requires a premarket submission, the applicable clearance or approval must be obtained before commercial distribution.
Importantly, FDA registration is not the same as FDA clearance or approval.
The FDA expressly states that establishment registration and device listing do not indicate that the FDA has cleared, approved or authorized a medical device. It also warns against misleading claims such as "FDA Certified" based solely on registration.
That matters for suppliers dealing with imported equipment or unfamiliar manufacturers.
Do not tell a clinic that a device is "FDA approved" merely because a seller presents an establishment-registration certificate.
Verify the actual regulatory status applicable to the product and its intended use.
The financing provider may also independently require satisfactory equipment or vendor verification before funding.
Canada uses different terminology and requirements.
Health Canada classifies medical devices into four risk classes. Class I is the lowest risk and Class IV the highest. Health Canada states that Class II, III and IV medical devices require a valid Medical Device Licence before they can be imported or sold in Canada.
Importers and distributors also generally require a Medical Device Establishment Licence for their applicable activities, including distribution of medical devices, subject to the regulations and applicable exemptions.
Health Canada maintains its Medical Devices Active Licence Listing so buyers and suppliers can verify whether applicable Class II, III or IV equipment has a current licence. Health Canada specifically recommends checking active status because licences can be suspended, cancelled or discontinued.
A Canadian supplier should therefore use licensed rather than "Health Canada cleared" when referring to applicable device authorization.
Financing does not replace this due diligence.
Assume a Canadian clinic purchases an aesthetic treatment system for CAD $160,000 before applicable taxes.
This example is educational only. It is not a Mehmi Financial Group quote, approval, available rate or customer result.
Assume the customer contributes CAD $20,000, leaving CAD $140,000 financed.
Assume an annual interest rate of 9.50%, a 60-month term, monthly payments, no balloon payment and a CAD $1,500 documentation fee paid separately. GST/HST/PST/QST, delivery, insurance, service plans, consumables and maintenance are excluded.
Using a standard fully amortizing calculation, the estimated monthly payment is approximately CAD $2,940.26.
Across 60 payments, scheduled repayment would total approximately CAD $176,415.64.
That represents approximately CAD $36,415.64 of interest on the CAD $140,000 financed amount.
Including the separate CAD $1,500 documentation fee, estimated financing cost would be approximately CAD $37,915.64, excluding the customer's initial contribution and other excluded expenses.
The assumed 9.50% rate is not being presented as an all-in APR because the separate fee has not been incorporated into an APR calculation.
From a credit perspective, the relevant question is whether another CAD $2,940 per month remains supportable during a slower booking period after rent, practitioners, payroll, existing equipment payments, marketing and other operating expenses.
Canadian clinics can model other equipment prices, contributions and terms using Mehmi's Equipment Financing Calculator. The live calculator uses CAD, excludes GST/PST/HST and states that the output is an estimate rather than a financing offer.
Medical equipment is one of the more frequently financed U.S. equipment categories.
The Equipment Leasing & Finance Foundation's 2024 Horizon Report estimated that 84% of U.S. medical-equipment acquisition volume in 2023 was financed through a lease, loan or line of credit. That is equipment-market research, not an aesthetic-clinic approval rate.
In Canada, Statistics Canada's 2023 Survey on Financing and Growth of SMEs found that 49.3% of SMEs with 1–499 employees requested at least one form of external financing, including debt, leases, trade credit, equity and government financing. This is national SME data, not aesthetic-industry data.
The practical point for suppliers is not that every clinic should finance its purchase.
It is that third-party financing is already a normal capital-acquisition tool and can be incorporated into the sales process without forcing the supplier to carry the customer receivable.
The financing structure should reflect the device and buyer.
A clinic expecting to keep a durable treatment system for many years may prefer an ownership-oriented structure.
A clinic purchasing rapidly evolving technology may care more about end-of-term flexibility and upgrade options.
Leases can contain residuals, purchase options or return requirements. Those obligations need to be understood before the clinic chooses based only on the lowest monthly payment.
For Canadian customers comparing those structures, Mehmi's Medical & Dental Equipment Financing Canada: Best Options provides a useful ownership-versus-flexibility framework.
A supplier can also use more than one financing provider when its transactions vary significantly.
The goal should be appropriate lender matching, not sending every applicant indiscriminately to every financing company.
Multiple financing providers do not guarantee approval or lower pricing.
Medical and aesthetic financing applications can contain sensitive owner and guarantor information.
The sales representative generally does not need copies of every bank statement, ID document or personal credit authorization sitting in their inbox.
A cleaner model is a secure application that collects the initial business information and allows underwriting documents to be requested only when required.
Mehmi's Online Credit Application for Equipment Dealers describes a staged approach where basic intake comes first and more extensive documentation is triggered by the actual credit file.
That can be especially useful for aesthetic suppliers with multiple sales representatives.
The salesperson can continue selling equipment while the finance partner manages the confidential credit process.
Potentially.
A co-branded or white-label application can keep the financing experience connected to the supplier while an independent third party handles underwriting and funding.
Mehmi's White Label Equipment Financing for Dealers explains how branding can remain with the equipment seller without turning the seller into the lender.
The distinction should remain clear in customer communications.
The supplier should not say "we approved you" if an independent financing institution made the credit decision.
Similarly, the supplier should not promise a final rate, term or approval before the financing provider completes underwriting.
Credit approval is not the same as funded proceeds.
Before releasing payment, the financing provider may still require a final invoice, signed financing documents, proof of customer contribution, device serial number, insurance where required, vendor verification, delivery evidence or customer acceptance.
Used equipment can require additional condition and ownership verification.
Installation-intensive equipment can create another question: does the supplier get paid when the device ships, when it is installed or after the clinic signs an acceptance certificate?
Those requirements should be known before delivery.
Mehmi's Equipment Financing Process: Step-by-Step Canada separates conditional approval, documentation, security setup and funding into distinct stages.
The supplier's internal sales process should make the same distinction.
Financing should not turn an uneconomic equipment purchase into an apparently affordable one.
A clinic may be better off waiting if existing equipment payments already strain cash flow.
Purchasing one versatile platform may make more sense than financing several devices simultaneously before treatment demand is proven.
Used equipment can provide better economics when the technology remains supported and the clinic does not require the newest platform.
A larger cash contribution can reduce fixed debt service when the clinic has excess liquidity.
The customer should also be cautious when the only way the financing works is by assuming immediate full utilization after installation.
A strong supplier financing program should help viable clinics acquire productive equipment—not push every prospect toward the largest possible financed package.
Yes. A supplier can work with independent commercial financing providers or a financing brokerage while remaining the equipment seller. The independent provider makes the actual credit and funding decision.
Potentially. A package can be reviewed as one transaction when the quote clearly identifies the base platforms, handpieces, accessories, software, installation and other costs. Provider eligibility still varies.
Potentially. Age, condition, maintenance history, device regulatory status, software transfer, service support, included handpieces and remaining useful life can all affect underwriting.
Some providers consider newer businesses. Owner credit, industry experience, liquidity, location readiness, customer contribution and the size of the initial equipment package can become more important when historical business cash flow is limited.
Some initial consumables may be permitted by certain providers when closely tied to an equipment package, but recurring consumables generally represent operating expenses rather than durable equipment. The invoice should identify them separately.
No. The FDA explicitly states that establishment registration and device listing do not constitute device clearance, approval or authorization. The actual regulatory status of the specific device should be verified.
It depends on classification. Health Canada states that Class II, III and IV medical devices require a valid Medical Device Licence before import or sale in Canada. Class I devices do not require an MDL, although establishment-licensing requirements can still apply to manufacturers, importers or distributors.
No. Mehmi Financial Group's current disclaimer states that it operates as a commercial financing broker and intermediary rather than a direct lender. Independent third-party financing institutions make final approval, pricing and funding decisions.
A useful supplier financing program should reflect the systems and clinics your company actually serves.
When discussing the program with Mehmi Financial Group, be prepared to share your typical financing amount, whether customers are located in the United States, Canada or both, the relevant state or province, the equipment and customer use of funds, whether devices are new or used, how much of the invoice consists of software, service or consumables, and the required delivery and funding timing.
Mehmi Financial Group acts as a commercial financing brokerage and intermediary. Independent financing providers determine final approval, pricing, documentation, collateral requirements and funding.
Call 833-863-4644 or use the verified Mehmi Financial Group contact page to discuss a customer-financing program for your aesthetic equipment supply business. The current contact page confirms 1-833-863-4644.
.svg){kind=small}